Cosmetics
-
BSE And Cosmetics: FDA Risk Assessment and Management Perspectives - Slide 1
December 7, 2006
First | ← Previous | Slide 1 of 45 | Next → | Last | Index

BSE and Cosmetics:
FDA Risk Assessment and Management Perspectives.
Stanley R. Milstein, Ph.D., Office of Cosmetics and Colors
CFSAN-Australian Embassy Presentation
December 7, 2006
-
-







